NASDAQ · Biotechnology

IRON (IRON) Stock

$73.86 -1.01% NASDAQ: IRON Healthcare

Valuation

MetricValue
Price$73.86
Market Cap$2.82B
P/E Ratio-9.08
P/B Ratio3.80
P/S Ratio0.00
EPS (TTM)$-6.64
52-Week High$99.50
52-Week Low$40.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-35.83%
ROA-22.67%
ROCE-31.89%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.05
Current Ratio24.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-31.0M$-47.0M$-91.0M$-130.0M$-236.0M
Net Profit$-36.0M$-47.0M$-76.0M$-109.0M$-212.0M
EPS$-44.88$-45.05$-3.42$-3.96$-6.01
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$92.0M$200.0M$368.0M$497.0M$807.0M
Total Liabilities$157.0M$24.0M$23.0M$53.0M$67.0M
Cash$88.0M$195.0M$360.0M$192.0M$91.0M
Borrowings$7.0M$1.0M$2.0M$30.0M$2.0M

Latest News

Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing MT Newswires · Jun 23, 2026 Disc Medicine Insider Sold Shares Worth $1,287,801, According to a Recent SEC Filing MT Newswires · Jun 18, 2026 Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting GlobeNewswire · Jun 12, 2026 Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-42.0M$-73.0M$-94.0M$-180.0M
Investing Cash Flow$0$0$0$-293.0M$-395.0M
Financing Cash Flow$5.0M$95.0M$40.0M$2.0M$1.0M
Net Cash Flow$62.0M$107.0M$166.0M$-168.0M$-101.0M
Free Cash Flow$-28.0M$-42.0M$-74.0M$-94.0M$-181.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.15
EV / EBITDA-7.26
FCF Yield-7.69%
Quick Ratio24.00
Interest Coverage-59.00
Return 1Y22.36%
Return 3Y62.24%
Return 5Y-47.85%

Ownership

Insiders Held7.78%
Institutions Held113.48%
Institutions Float Held123.05%
Institutional HolderSharesReport Date
FMR, LLC5,586,8942026-03-31
RA Capital Management, L.P.2,450,2212026-03-31
Blackrock Inc.2,273,8312026-03-31
Wellington Management Group, LLP1,735,3762026-03-31
State Street Corporation1,698,2442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPGAscentage Pharma Group International $20.18 +4.89% -9.87 $1.88B 0.00%
ADPT $24.93 +5.64% -69.84 $3.99B 0.00%
APGE $134.19 +0.06% -16.89 $8.30B 0.00%
CELC $92.49 +5.44% -91.68 $4.51B 0.00%
CGON $72.17 -1.84% -26.72 $6.37B 0.00%

About IRON

IRON stock trades at $73.86 with a market capitalization of $2.82B. The stock is valued at a price-to-earnings (P/E) ratio of -9.08, price-to-book of 3.80, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $40.00 and $99.50, and currently trades 25.8% below its 52-week high.

On profitability, IRON generates a return on equity (ROE) of -35.83%, return on capital employed of -31.89%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides